Tremelimumab plus Durvalumab Prior to Chemoradiotherapy in Unresectable Locally Advanced NSCLC, the Induction Trial

被引：0
|
作者：
Smeenk, M. M. [1 ]
van Diessen, J. N. A. [1 ]
Boellaard, T. N. [1 ]
Hartemink, K. J. [1 ]
de Vries, J. F. [1 ]
Badrising, S. K. [1 ]
Wondergem, M. [1 ]
Wittenberg, R. [1 ]
Monkhorst, K. [1 ]
van den Heuvel, M. M. [2 ]
Theelen, W. S. M. E. [1 ]
机构：
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Induction; Immunotherapy; Locally advanced NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA16.03
引用
收藏
页码：S157 / S157
页数：1
相关论文
共 50 条
  • [21] Safety and activity of second-line durvalumab plus tremelimumab in non-squamous advanced NSCLC
    Chaft, Jamie
    Cho, Byoung Chul
    Ahn, Myung-Ju
    Le Moulec, Sylvestre
    Cho, Eun Kyung
    Papadimitrakopoulou, Vassiliki
    Garon, Edward
    Lee, Sylvia
    Aix, Santiago Ponce
    Ma, Patrick C.
    Otterson, Gregory
    Narwal, Rajesh
    Gao, Guozhi
    McDevitt, Jennifer
    Englert, Judson
    Antonia, Scott
    CANCER RESEARCH, 2018, 78 (13)
  • [22] Change in Liver Function in Durvalumab Plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma
    Tamaki, Nobuharu
    Mori, Nami
    Takaki, Shintaro
    Tsuji, Keiji
    Tada, Toshifumi
    Nakamura, Shinichiro
    Ochi, Hironori
    Mashiba, Toshie
    Doisaki, Masao
    Marusawa, Hiroyuki
    Kobashi, Haruhiko
    Fujii, Hideki
    Ogawa, Chikara
    Nonogi, Michiko
    Arai, Hirotaka
    Uchida, Yasushi
    Urawa, Naohito
    Narita, Ryoichi
    Akahane, Takehiro
    Kondo, Masahiko
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Izumi, Namiki
    Kurosaki, Masayuki
    ANTICANCER RESEARCH, 2024, 44 (09) : 3913 - 3918
  • [23] A retrospective analysis of locally advanced EGFR-mutated NSCLC patients with durvalumab after chemoradiotherapy
    Uchida, Yoshiyasu
    Ninomiya, Takashi
    Harada, Daijiro
    Kozuki, Toshiyuki
    ANNALS OF ONCOLOGY, 2022, 33 : S488 - S488
  • [24] Treatment and clinical outcome in recurrent/refractory locally advanced NSCLC following chemoradiotherapy and consolidative durvalumab
    Evers, G.
    Reitnauer, L. E.
    Christoph, D. C. C.
    Brueckl, W. M.
    Wiesweg, M.
    Glanemann, F.
    Webendoerfer, M.
    Kropf, C.
    Acker, F.
    Hund, A-C.
    Schuette, W.
    Hoffknecht, P.
    Kerkhoff, A.
    Mohr, M.
    Lenz, G.
    Frost, N.
    Overbeck, T. R.
    Sebastian, M.
    Bleckmann, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S749 - S749
  • [25] Phase I/II Trial of Durvalumab and Tremelimumab with Continuous or Intermittent MEK Inhibitor Selumetinib in Advanced NSCLC
    Gaudreau, P.
    Heymach, J.
    Gibbons, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S722 - S723
  • [26] Phase II Study of Durvalumab Plus Concurrent Radiotherapy in Unresectable Locally Advanced NSCLC: DOLPHIN Study (WJOG11619L)
    Tachihara, M.
    Tsujino, K.
    Shimokawa, M.
    Ishihara, T.
    Hayashi, H.
    Sato, Y.
    Kurata, T.
    Sugawara, S.
    Shiraishi, Y.
    Teraoka, S.
    Azuma, K.
    Daga, H.
    Yamaguchi, M.
    Kodaira, T.
    Satouchi, M.
    Yamamoto, N.
    Nakagawa, K.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S64 - S64
  • [27] Platinum Doublet plus Durvalumab plus /- Tremelimumab in Patients with Advanced NSCLC: A CCTG Phase IB Study - IND.226
    Juergens, R.
    Ellis, P.
    Tu, D.
    Hao, D.
    Laurie, S.
    Mates, M.
    Goss, G.
    Goffin, J.
    Bradbury, P.
    Tehfe, M.
    Kollmansberger, C.
    Brown-Walker, P.
    Smoragiewicz, M.
    Tsao, M.
    Seymour, L.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S291 - S292
  • [28] A comparative safety analysis for durvalumab in patients with locally advanced, unresectable NSCLC: PACIFIC versus pooled durvalumab monotherapy studies.
    Antonia, Scott Joseph
    Hellmann, Matthew David
    Dennis, Phillip A.
    Melillo, Giovanni
    Abdullah, Shaad Essa
    Lloyd, Andrew
    Rizvi, Naiyer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [29] Chemoradiotherapy for Initially Unresectable Locally Advanced Cholangiocarcinoma
    Sumiyoshi, Tatsuaki
    Shima, Yasuo
    Okabayashi, Takehiro
    Negoro, Yuji
    Shimada, Yasuhiro
    Iwata, Jun
    Matsumoto, Manabu
    Hata, Yasuhiro
    Noda, Yoshihiro
    Sui, Kenta
    Sueda, Taijiro
    WORLD JOURNAL OF SURGERY, 2018, 42 (09) : 2910 - 2918
  • [30] Chemoradiotherapy for Initially Unresectable Locally Advanced Cholangiocarcinoma
    Tatsuaki Sumiyoshi
    Yasuo Shima
    Takehiro Okabayashi
    Yuji Negoro
    Yasuhiro Shimada
    Jun Iwata
    Manabu Matsumoto
    Yasuhiro Hata
    Yoshihiro Noda
    Kenta Sui
    Taijiro Sueda
    World Journal of Surgery, 2018, 42 : 2910 - 2918
12345